The ERA Registry Annual Report 2019: summary and age comparisons

Rianne Boenink (Lead / Corresponding author), Megan E. Astley, Jilske A. Huijben, Vianda S. Stel, Julia Kerschbaum, Mai Ots-rosenberg, Anders Åsberg, František Lopot, Eliezer Golan, Pablo Castro de la Nuez, Marta Rodríguez Camblor, Sara Trujillo-alemán, Juan Carlos Ruiz San Millan, Pablo Ucio Mingo, Juan Manuel Díaz, M. Encarnación Bouzas-Caamaño, Marta Artamendi, Manuel I. Aparicio Madre, Carmen Santiuste de Pablos, María Fernanda Slon RobleroOscar Zurriaga, Maria Stendahl, Samira Bell, Alma Idrizi, Kyriakos Ioannou, Alicja Debska-Slizien, Anna A. Galvão, Johan de Meester, Halima Resić, Kristine Hommel, Danilo Radunovic, Runolfur Palsson, Mathilde Lassalle, Patrik Finne, María De los Ángeles-Garcia Bazaga, Nikola Gjorgjievski, Nurhan Seyahi, Marjolein Bonthuis, Alberto Ortiz, Kitty J. Jager, Anneke Kramer

Research output: Contribution to journalArticlepeer-review

48 Citations (Scopus)
65 Downloads (Pure)


Background: Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry Annual Report, including data from 34 countries and additional age comparisons.

Methods: Individual patient data for 2019 were provided by 35 registries and aggregated data by 17 registries. Using these data, the incidence and prevalence of RRT, the kidney transplantation activity and the survival probabilities were calculated.

Results: In 2019, a general population of 680.8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these patients, 62% were men, 54% were ≥65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in the period 2010–14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities.
Original languageEnglish
Pages (from-to)452-472
Number of pages21
JournalClinical Kidney Journal
Issue number3
Early online date15 Dec 2021
Publication statusPublished - Mar 2022


  • dialysis
  • epidemiology
  • ESRD
  • graft survival
  • kidney transplantation
  • patient survival

ASJC Scopus subject areas

  • Nephrology
  • Transplantation


Dive into the research topics of 'The ERA Registry Annual Report 2019: summary and age comparisons'. Together they form a unique fingerprint.

Cite this